Myriad Genetics
MYGN
MYGN
205 hedge funds and large institutions have $1.98B invested in Myriad Genetics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 74 reducing their positions, and 22 closing their positions.
Holders
205
Holders Change
+8
Holders Change %
+4.06%
% of All Funds
3.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
65
Reduced
74
Closed
22
Calls
$7.18M
Puts
$811K
Net Calls
+$6.37M
Net Calls Change
-$1.84M
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$8.69M |
| 2 |
2
Goldman Sachs
New York
|
$39.6M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$106M |
| 4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$11M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$226M |
